Kimberlee C Drapkin
CIK 1340881 · President, CFO and Treasurer · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$114.5K
Companies
9
Total Filings
44
Lifetime Open-Market Net
-$827.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Climb Bio, Inc. (ELYM) Delisted | Director | — | $5.11 | — | $0 | 3 | 2026-06-08 |
| ABOS | Director | 48,300 | $2.37 | $114.5K | $0 | 6 | 2026-06-05 |
| LENZ | Director | — | $6.77 | — | $0 | 1 | 2025-06-11 |
| KINETA, INC./DE (KA) Delisted | Director | — | $0.57 | — | $0 | 2 | 2024-09-05 |
| LENZ Therapeutics, Inc. (GRPH) Delisted | Director | — | $22.26 | — | $0 | 1 | 2023-08-01 |
| Jounce Therapeutics, Inc. (JNCE) Delisted | President, CFO and Treasurer | 0 | $1.88 | $0 | -$827.4K | 18 | 2023-05-04 |
| KINETA, INC./DE (YMTX) Delisted | Director | — | $13.23 | — | $0 | 1 | 2021-06-04 |
| KINETA, INC./DE (PTI) Delisted | Director | — | — | — | $0 | 2 | 2020-07-01 |
| EPIX Pharmaceuticals, Inc. (EPIX) Delisted | Chief Financial Officer | 53,921 | $0.20 | $10.8K | $0 | 6 | 2009-03-19 |
Recent Filings · Page 2 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-25 | — | Grant (A) | — | $0 | |
| 2023-08-01 | LENZ Therapeutics, Inc. (GRPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-07-05 | KINETA, INC./DE (KA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-07 | ABOS | Grant (A) | — | $0 | EDGAR |
| 2023-05-04 | Jounce Therapeutics, Inc. (JNCE) Delisted | Mixed | −66,018 | $0 | EDGAR |
| 2023-01-11 | Jounce Therapeutics, Inc. (JNCE) Delisted | Sell (S) | −14,096 | -$15.7K | EDGAR |
| 2022-06-17 | ABOS | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | ABOS | Grant (A) | — | $0 | EDGAR |
| 2022-02-03 | Jounce Therapeutics, Inc. (JNCE) Delisted | Grant (A) | +27,500 | $0 | EDGAR |
| 2022-01-11 | Jounce Therapeutics, Inc. (JNCE) Delisted | Sell (S) | −12,817 | -$88.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.